09/30/2025 | Press release | Distributed by Public on 09/30/2025 13:11
Dehli, 30/09/2025 - Medtronic, a global leader in healthcare technology, has announced the launch of two advanced surgical energy generators in India under the Valleylab™ FT10 series - the Valleylab™ FT10 Electrosurgical Generator (VLFT10FXGEN) and the Valleylab™ FT10 Vessel Sealing Generator (VLFT10LSGEN). Both devices are USFDA-approved and CE-marked, providing Indian hospitals with access to adaptive surgical technology designed to enhance precision, safety and efficiency in the operating room. This launch builds on the trusted Valleylab™ portfolio which for over 50 years has supported surgeons worldwide with reliable performance and improved patient outcomes.
The Valleylab™ FT10 is a smart surgical device that helps doctors perform operations more safely and efficiently. It uses controlled energy to cut or seal tissue during procedures. What makes it special is its TissueFect™ sensing technology, which automatically adjusts the energy based on the type of tissue being treated. This means surgeons get more precise results, with less risk and faster recovery for patients.i, ii Operating rooms are highly dynamic environments with variability stemming from patient anatomy, disease states, comorbidities, equipment differences, surgical field conditions and team coordination. The Valleylab™ FT10 energy platform tackles these challenges by monopolar, bipolar and LigaSure™ technologies. Its advanced sensors and rapid processing capabilities enable algorithms to deliver energy consistently, adapting in real time to changing surgical conditions. This adaptability allows operating room teams to concentrate on the patient, perform procedures with greater confidence and achieve precise energy delivery. It also supports shorter surgery times, faster patient recovery and more efficient use of hospital resources.1
Commenting on the product launch, Abhishek Bhargava, Senior Director, Medical Surgical, Medtronic India said, "The launch of the New Valleylab™ FT10 Family of Generators in India is an important milestone in our journey to expand access to advanced healthcare solutions in India. With the Valleylab™ FT10, we are equipping clinicians with advanced tools for safer, faster and more precise procedures, while also supporting healthcare professionals and hospitals in delivering cost-effective and high-quality care."
To support the launch, Medtronic will roll out comprehensive training and education programs for surgeons and operating room staff at hospitals, ensuring seamless adoption of the Valleylab™ FT10 Family of Generators. The company also plans a phased expansion to make the technology available nationwide, reinforcing its commitment to deliver world-class surgical solutions to patients in India.
For further information, please contact:
Medtronic Public Relations
Masooma Pathre
[email protected]
Medtronic Investor Relations
Ryan Weispfenning
+1-763-505-4626
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. All details contained in this release are for general awareness purposes only and do not constitute medical advice.
1 May, R., Buysse, S., McHenry, J., Wagle, K., & Dunning, J. (2016). Valleylab™ FT10 Energy Platform White Paper. Medtronic. Reference #835935. [PDF]